Open AccessAbstract 5025: EZH2 reprogramming confers intrinsic stem cell properties and developmental plasticity driving neuroendocrine prostate cancer
Author(s) -
Alastair Davies,
Ahmed Musa,
Chiara Bostock,
Anna Gleave,
Kirsi Ketola,
Fraser Johnson,
Jennifer Bishop,
Ladan Fazli,
Haojie Huang,
Hansen He,
Amina Zoubeidi
Publication year - 2017
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2017-5025
Subject(s) - reprogramming , transdifferentiation , prc2 , biology , cancer research , enzalutamide , ezh2 , prostate cancer , cancer stem cell , embryonic stem cell , androgen receptor , epigenome , cancer , microbiology and biotechnology , stem cell , cell , histone , genetics , dna methylation , gene expression , gene